From: Prospective assessment of the gastroesophageal microbiome in VLBW neonates
Summary of demographic and clinical data | |
---|---|
Prenatal characteristics | n = 12 infants |
Gestational age in weeks | 29.2 ± 0.7* (24–32) |
Birth weight in grams | 1140 ± 72* (580–1390) |
Male sex | 8 (67%) |
Cesarean section | 10 (83%) |
Maternal antenatal steroids | 12 (100%) |
Maternal antenatal antibiotics | 6 (50%) |
Maternal chorioamnionitis | 2 (17%) |
Prolonged rupture of membranes | 4 (33%) |
Postnatal characteristics | |
RDS requiring intubation/surfactant | 9 (75%) |
RDS requiring CPAP - high flow nasal cannula | 3 (25%) |
Umbilical artery or vein catheterization | 11 (92%) |
PICC line placement | 12 (100%) |
Antacid use (famotidine) | 6 (50%) |
Antibiotics in first 48 hrs | 11 (92%) |
Positive blood culture (late onset sepsis) | 1 |
Positive tracheal culture | 3 (25%) |